Trial intelligence / Profile preview

Sildenafil for diastolic dysfunction after acute myocardial infarction

2009-011006-42Phase 4Completed

Sponsor
Rigshospitalet
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in diastolic dysfunction and myocardial infarction (MI) comparing Sildenafil with Placebo (2 arms). Primary endpoints: Diastolic function parameters and Exercise capacity. Started Jun 2009; status: completed.

02

Drugs

sildenafil
03

Conditions

diastolic dysfunctionmyocardial infarction (MI)

Beyond the preview

Go deeper on 2009-011006-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011006-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call